We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sigma Introduces the MyriaScreen Diversity Collection
Product News

Sigma Introduces the MyriaScreen Diversity Collection

Sigma Introduces the MyriaScreen Diversity Collection
Product News

Sigma Introduces the MyriaScreen Diversity Collection


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Sigma Introduces the MyriaScreen Diversity Collection "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sigma-Aldrich has announced the availability of the MyriaScreen Diversity Collection of drug-like screening compounds.

The collection, produced in collaboration with TimTec Inc., is the result of careful evaluation, filtering, and refinement of selections from each of Sigma’s screening compound collections.

The MyriaScreen Diversity Collection is comprised of 10,000 high-purity screening compounds handpicked to maximize chemical diversity while maintaining drug-likeness.

The MyriaScreen Diversity Collection was assembled from a pool of over 300,000 screening compounds using a combination of filters, diversity predictors, and manual selection.

The resulting 10,000 compounds are drug-like, chemically diverse, and amenable to follow-up chemistry and optimization.

The collection is well suited for researchers that are looking for a small, cost-effective, ready-to-screen set of high-quality screening compounds.

“MyriaScreen will complement our customers' existing screening collections and jump-start new collections by quickly adding interesting chemotypes,” said Michael Earley, Product Manager, Drug Discovery, Sigma-Aldrich.

“Our collaboration with TimTec, Inc. resulted in a high-quality library that our customers will find useful.”

Advertisement